Beam Therapeutics Inc. — Director's Dealing 2021

Aug 16, 2021

SEC Form 4/A — Form 4/A

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-08-06

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-06	Common Stock	J	745393	—	Disposed	6226519	Indirect
2021-08-06	Common Stock	J	7454	—	Acquired	7454	Indirect
2021-08-06	Common Stock	J	7454	—	Disposed	0	Indirect
2021-08-06	Common Stock	J	724	—	Acquired	724	Indirect
2021-08-06	Common Stock	J	447236	—	Acquired	1160583	Indirect
2021-08-09	Common Stock	J	1160430	—	Disposed	153	Indirect
2021-08-09	Common Stock	J	950485	—	Acquired	950485	Indirect

Footnotes

F1: These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.

F2: This amendment is being filed to include missing holdings from Table 1 by persons and entities whose shares are subject to reporting by the undersigned and report FMR LLC still subject to Section 16.